Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

Inclusion Criteria: * Considered to be healthy as judged from vital signs, medical history, ECG (electrocardiogram), laboratory values, and physical examination * Body mass index between 18 and 27 kg/m\^2 (both inclusive) * Non-smoker * Fasting blood glucose maximum 6 mmol/L * HbA1c below 6.4% Exclusion Criteria: * Pregnant or breast-feeding women * Women not using acceptable methods of contraception without difficulties for at least three months prior to trial start (screening), including intrauterine devices, oral contraceptives, hormonal implants, or sterilisation * Clinically significant abnormal laboratory values (as judged by the Investigator) * Close relative with type 1 diabetes mellitus (father, mother, sister or brother) * Intake of alcohol within the last 24 hours prior to screening and drug administration visits * Blood donation or blood loss of more than 500 mL within the 3 last months before screening * Strenuous exercise within 48 hours before screening as well as drug administration and followup * Smoking during the past month before drug administration